Boxer Capital’s ESSA Pharma EPIX Stock Holding History

Boxer Capital’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-724,500	Closed	-$2.28M	–	77
2022 Q2	$2.28M	Hold	724,500	–	–	0.14%	65
2022 Q1	$4.49M	Hold	724,500	–	–	0.23%	58
2021 Q4	$10.3M	Buy	724,500 +37,500	+5%	+$418K	0.41%	46
2021 Q3	$5.5M	Hold	687,000	–	–	0.19%	67
2021 Q2	$19.6M	Hold	687,000	–	–	0.69%	45
2021 Q1	$20M	Buy	+687,000	New	+$16M	0.68%	42
2016 Q4	–	Sell	-1,405	Closed	-$74K	–	31
2016 Q3	$74K	Hold	1,405	–	–	0.04%	28
2016 Q2	$83K	Hold	1,405	–	–	0.07%	23
2016 Q1	$91K	Hold	1,405	–	–	0.09%	21
2015 Q4	$119K	Buy	+1,405	New	+$147K	0.1%	15

Other funds holding EPIX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return